Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Replimune Group, Inc. - Common Stock
(NQ:
REPL
)
10.00
+0.18 (+1.83%)
Streaming Delayed Price
Updated: 10:16 AM EST, Dec 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Replimune Group, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
↗
March 27, 2022
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Via
Benzinga
Replimune Group: Q3 Earnings Insights
↗
February 03, 2022
Replimune Group (NASDAQ:REPL) reported its Q3 earnings results on Thursday, February 3, 2022 at 08:00 AM.
Via
Benzinga
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
↗
February 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
February 18, 2022
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
January 20, 2022
During Thursday's morning trading, 152 companies set new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Rivian Automotive (NASDAQ:RIVN) was the largest...
Via
Benzinga
10 Biggest Price Target Changes For Monday
↗
August 23, 2021
Telsey Advisory Group boosted the price target for Burlington Stores, Inc. (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
June 03, 2021
Gainers Kindred Biosciences (NASDAQ:KIN) shares increased by 24.08% to $6.75 during Thursday's regular session. Kindred Biosciences's stock is trading at a volume...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
↗
November 19, 2021
Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE:
Via
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
↗
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
↗
June 03, 2021
Gainers GTT Communications, Inc. (NYSE: GTT) shares jumped 66% to $4.16 on abnormally-high volume. The company’s stock also jumped over 57% on Wednesday. Ra Medical Systems...
Via
Benzinga
55 Biggest Movers From Yesterday
↗
June 04, 2021
Gainers DLocal Limited (NASDAQ: DLO) shares jumped 54.2% to close at $32.39 on Thursday. DLocal raised around $92.6 million from the sale of 4.4 million shares in its IPO. GTT...
Via
Benzinga
Topics
Initial Public Offering
The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout
↗
June 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 05, 2021
Gainers Chiasma (NASDAQ:CHMA) shares moved upwards by 41.9% to $4.03 during Wednesday's regular session. Chiasma's stock is trading at a volume of 75.5 million...
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.